课题基金 / 基金详情

Cellular immune responses in AIDS virus controllers

Cellular immune responses in AIDS virus controllers
艾滋病病毒控制者的细胞免疫反应
批准号:
23390115
负责人:
MATANO TETSURO
金额:
$12.81万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2011
资助国家:
日本
项目状态:
已结题
起止时间:
2011-04-01 至 2014-03-31

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
To elucidate the mechanism for sustained control of HIV replication, this study analyzed vaccinated rhesus macaques that controlled simian immunodeficiency virus (SIV) replication for more than 2 years after challenge. Remarkably, half of these SIV controllers had multiple proviral gag and nef mutations at 2 years whereas the remaining half did not. At 1 year, the former group showed broader cytotoxic T lymphocyte (CTL) responses targeting viral non-Gag/Nef proteins as well as Gag/Nef, whereas Gag- and Nef-specific CTL responses were still dominant in the latter. The latter group represents an extremely stable SIV control by Gag/Nef-specific CTLs, providing a possible mechanism of functional HIV cure by CTLs.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Efficacy of single epitope-specific cytotoxic T lymphocyte induction by vaccination against a simian immunodeficiency virus challenge
通过针对猿猴免疫缺陷病毒攻击的疫苗接种诱导单表位特异性细胞毒性 T 淋巴细胞的功效
DOI: --
发表时间: 2011
期刊:
影响因子: --
作者: [Ishii H, Iwamoto N, Matsuoka S, Inoue M, Iida A, Hara H, Shu T, Hasegawa M, Naruse T, Kimura A, Matano T]
通讯作者: Matano T
Efficacy of single epitope-specific cytotoxic T lymphocvte induction by vaccination against a simian immunodeficiency virus challenge
通过针对猿猴免疫缺陷病毒攻击的疫苗接种诱导单表位特异性细胞毒性 T 淋巴细胞的功效
DOI: --
发表时间: 2011
期刊:
影响因子: --
作者: [石井洋, 他]
通讯作者:
Dominant induction of vaccine antigen-specific cytotoxic T lymphocyte responses after simian immunodeficiency virus challenge.
猿猴免疫缺陷病毒攻击后,显着诱导疫苗抗原特异性细胞毒性 T 淋巴细胞反应。
DOI: 10.1016/j.bbrc.2011.04.071
发表时间: 2011
期刊: Biochemical and Biophysical Research Communications
影响因子: 3.1
作者: [Takahara, Y.]
通讯作者: Y.
エイズワクチン開発
艾滋病疫苗研发
DOI: --
发表时间: 2012
期刊:
影响因子: --
作者: [Silsirivanit A, et al, 俣野哲朗]
通讯作者: 俣野哲朗
37
    海外基金